ABBV
AbbVie Inc.
$294.45−0.53 (−0.18%)Close Nov 12, 2026
Jan 2, 2013 – Nov 12, 2026, Dividends reinvested
- Final balance
- $145,112
- CAGR
- +21.29%
- Max drawdown
- −45.09%
- Sharpe ratio
- 0.87
Loading the growth chart…
Growth of $10,000
Trailing returns (%)
ABBV's average annual return was 21.50% over the last 10 years, through Nov 12, 2026. $10,000 in ABBV on Nov 11, 2016 grew to $70,130 by Nov 12, 2026, with dividends reinvested.
Total
- 1M
- +5.38%
- 3M
- +19.09%
- 6M
- +43.54%
- YTD
- +32.72%
- 1Y
- +30.03%
Per year
- 3Y
- +32.90%
- 5Y
- +24.63%
- 10Y
- +21.50%
- Since 2013
- +21.29%
Annual returns
2026 through Nov 12
ABBV returns by year
| Year | Return |
|---|---|
| 2026 through Nov 12 | +32.72% |
| 2025 | +33.08% |
| 2024 | +18.86% |
| 2023 | −0.23% |
| 2022 | +24.01% |
| 2021 | +32.43% |
| 2020 | +27.72% |
| 2019 | +1.47% |
| 2018 | −0.96% |
| 2017 | +60.07% |
| 2016 | +9.79% |
| 2015 | −6.50% |
| 2014 | +27.92% |
| 2013 | +56.38% |
Metrics
Since 2013| Volatility | 26.28% |
|---|---|
| Sortino ratio | 1.23 |
| Calmar ratio | 0.47 |
| Best year, 2017 | +60.07% |
| Worst year, 2015 | −6.50% |
| Positive years | 10 of 13 |
| Longest drawdown | 2.9 years |
Worst drawdowns
Since 2013| Decline | Peak | Bottom | Recovered | Length |
|---|---|---|---|---|
| −45.1% | Jan 2018 | Aug 2019 | Dec 2020 | 2.9 years |
| −31.6% | Jul 2015 | Oct 2015 | May 2017 | 1.8 years |
| −21.9% | Apr 2022 | Sep 2022 | Jan 2024 | 1.8 years |
| −20.7% | Mar 2025 | Apr 2025 | Sep 2025 | 6 months |
| −19.8% | Dec 2014 | Feb 2015 | Jun 2015 | 6 months |